CLINICAL APPLICATIONS
Horizontal transformation stories across hematology automation, connected ICU monitoring and remote care programs.
TRANSFORMATION PILLARS
CBC autovalidation, reflex differentials and LIS middleware (HL7 v2.5.1 ORM/ORU) reduce worksheet touchpoints when CAP/CLIA oversight stays centralized. Best fit when overnight menu breadth and QC traceability outweigh bedside minute-scale TAT.
Assay menu governance, open-vial stability windows and CAP proficiency alignment for high-complexity sites. CV targets and calibration intervals remain lot-linked—never inferred across CA / CS families.
Telemetry walls with HL7 FHIR Observation streaming and IEC 60601-1-8 alarm priority design. SpO2 accuracy bands and battery runtime must match the cleared monitor family before capital sign-off.
Downstream digital review hooks for flagged CBC morphology and smear workflow orchestration. Morphology claims stay IFU-bound; AI assist features require separate regulatory pathway confirmation.
Remote neurology consult paths that depend on reliable waveform and vitals transport. Latency budgets and failover routes belong in the interface validation packet, not marketing slides.
Remote patient monitoring with FDA cybersecurity documentation, SBOM/MDS² packets and HIPAA-aligned cloud residency. Home endpoints do not inherit hospital LIS assumptions.
Trade-off cue — Centralized core laboratory vs. distributed POCT: core labs win on automation scale, broader overnight menus and simpler accreditation oversight; POCT wins on minute-scale bedside TAT and fewer transport pre-analytics. Sysmex routes either strategy only after the site states which decision criterion is primary.
TRANSFORMATION CASES
Figures below are planning envelopes from controlled dossiers (2019–2024 cohorts). They are not transferable outcome guarantees across markets or SKUs.
Background: dual-campus hematology fleet with rising STAT CBC demand. Process: phased XN-class autovalidation rules + middleware reflex differentials under CAP checklist. Result: worksheet touches reduced in the project dossier; median TAT deltas remain site-owned and are not republished here as universal claims.
Background: three campuses with divergent coagulation menus. Process: shared QC lots, HL7 middleware harmonization and CLIA complexity re-map. Result: menu parity documented for the contracted assay list; CV and LOD stay lot-specific per package insert.
Background: hub-and-spoke neurology coverage with intermittent WAN links. Process: FHIR Observation + waveform transport validated against each spoke interface engine before go-live. Result: failover route acceptance recorded; clinical door-to-needle metrics remain hospital-owned outcomes.
Known limits: satellite POCT cannot replace high-complexity coagulation menus; home monitoring does not meet ICU alarm-priority profiles; LIS mappings fail without a site-specific interface validation packet.
